Chronic in vivo nicotine treatment increases CYP2E1

被引：0
|
作者：
Howard, LA [1 ]
Miksys, SL [1 ]
Zhang, WJ [1 ]
Sellers, EM [1 ]
Tyndale, RF [1 ]
机构：
[1] Univ Toronto, CAMH, Dept Pharmacol, Toronto, ON, Canada
来源：
FASEB JOURNAL | 2001年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A549 / A549
页数：1
相关论文
共 50 条
  • [21] INCREASED STABILITY OF MITOCHONDRIAL CYP2E1 AGAINST DEGRADATION COMPARED TO MICROSOMAL CYP2E1
    Hartman, Jessica H.
    Caro, Andres A.
    Ronis, Martin J.
    Miller, Grover P.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S54 - S54
  • [22] Chlorzoxazone: An in vitro and in vivo substrate probe for liver CYP2E1
    Lucas, D
    Menez, JF
    Berthou, F
    CYTOCHROME P450, PT B, 1996, 272 : 115 - 123
  • [23] Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications
    Schoedel, KA
    Tyndale, RF
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1619 (03): : 283 - 290
  • [24] DRINKING PREFERENCE OF CATALASE, CYP2E1, AND CATALASE/CYP2E1 DOUBLE KNOCKOUT MICE
    Heit, C.
    Charkoftaki, G.
    Fritz, K.
    Vasiliou, V.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 74A - 74A
  • [25] CYP2E1*1D regulatory polymorphism:: association with alcohol and nicotine dependence
    Howard, LA
    Ahluwalia, JS
    Lin, SK
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS, 2003, 13 (06): : 321 - 328
  • [26] Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics
    Howard, LA
    Miksys, S
    Hoffmann, E
    Mash, D
    Tyndale, RF
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (07) : 1376 - 1386
  • [27] Polymorphisms of the CYP2E1 in Koreans
    Park, K
    Mok, J
    KOREAN JOURNAL OF GENETICS, 2002, 24 (02): : 149 - 155
  • [28] Clinical interest of the in vivo measurement of CYP2E1 in alcoholic liver diseases
    Lucas, D
    Menez, C
    DuPont, I
    Bodenez, P
    Bardou, LG
    Berthou, F
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (03) : 745 - 746
  • [29] Reliability of chlorzoxazone as an in vivo probe of CYP2E1 activity in humans.
    Ernstgård, L
    Rannug, A
    Warholm, M
    Johanson, G
    TOXICOLOGICAL SCIENCES, 2003, 72 : 319 - 319
  • [30] CYP2E1 is not specific for formation of 6-hydroxychlorzoxazone in vivo.
    Wolf, KK
    Wood, S
    Bement, J
    Bement, W
    Wrighton, S
    Jeffery, E
    Gonzalez, F
    Sinclair, P
    Sinclair, J
    TOXICOLOGICAL SCIENCES, 2003, 72 : 318 - 318
12345